In Nation Healthcare Security Administration’s (NHSA’s) announcement for the 2025 NRDL, the government’s support for ...

A series of class actions over the exclusion of coverage for GLP-1 weight loss drugs is testing several legal strategies ...

The U.S. Food and Drug Administration has approved Cytokinetics' oral drug to treat a rare heart condition, the company said ...

The Central Drugs Standard Control Organisation (CDSCO) has launched a new risk classification module on the drug regulator's online system for medical devices in order to simplify the regulatory ...

At least 12% of adults in the U.S. have been prescribed a glucagon‐like peptide‐1 drug for one or multiple indications, but ...

Ryan Wedding rose to fame as a Canadian Olympic athlete, but the authorities say he became one of the world’s biggest drug ...

Donald Trump made an appearance at Mar-a-Lago last week to announce a "Golden Fleet" of Trump-class battleships. During Q&A ...

Numerous recalls have been issued due to potential damage, foodborne illness, contamination and undeclared food allergens.

IRLAB Therapeutics AB Class A ( ($SE:IRLAB.A) ) has provided an announcement. IRLAB Therapeutics has obtained regulatory and ethical approval to ...

An executive order signed by President Trump aims to classify marijuana as a less dangerous and more accessible drug.

President Donald Trump signed an executive order Dec. 18 calling on federal officials to finish reclassifying marijuana as a less dangerous drug — a major shift in federal drug policy that could […] ...

Povorcitinib is a selective oral small-molecule JAK1 inhibitor, with compound and use patents in certain countries/regions in the Territory. Currently, povorcitinib is in Phase 3 clinical trials for ...